Andros Pharmaceuticals Co., Ltd.
繁體中文
English
About Us
Overview
Milestones
Shareholders
Management
Technology/Product
New Dosage Form
Super Generics
High-End Cosmetic Ingredient
Gene Delivery System
News
Careers
Contact Us
Home
>
News
APC101 forthe indication above the neckhas sent to TFDA for Phase II clinical trials application.
Copyright ©
Andros Pharmaceuticals Co., Ltd. All rights reserved.